UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000041818
Receipt number R000043852
Scientific Title Relationship between short-, intermediate- and long-term glucose variability and oxidative stress in type 2 diabetes
Date of disclosure of the study information 2021/01/01
Last modified on 2022/01/04 01:22:19

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Relationship between short-, intermediate- and long-term glucose variability and oxidative stress in type 2 diabetes

Acronym

Relationship between short-, intermediate- and long-term glucose variability and oxidative stress in type 2 diabetes

Scientific Title

Relationship between short-, intermediate- and long-term glucose variability and oxidative stress in type 2 diabetes

Scientific Title:Acronym

Relationship between short-, intermediate- and long-term glucose variability and oxidative stress in type 2 diabetes

Region

Japan


Condition

Condition

Type 2 diabetes mellitus

Classification by specialty

Endocrinology and Metabolism

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

This study evaluated the effects of short-, intermediate- and long-term glucose variabilities on oxidative stress in patients with type 2 diabetes mellitus.

Basic objectives2

Others

Basic objectives -Others

cross-sectional study

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

the relationship between short-, intermediate- and long-term glucose variabilities and oxidative stress in patients with type 2 diabetes mellitus

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

outpatients of type 2 diabetes mellitus

Key exclusion criteria

1)the use of steroids or anti-inflammatory drugs,
2)diabetic ketosis and coma within 3 months before the study,
3)severe infection, severe trauma, pre-and post-operation,
4)an estimated glomerular filtration rate are within 30mL/min/1.73m2,
5)severe liver dysfunction,
6)malignancy,
7)pregnancy,
8)Patients who are judged as inappropriate for inclusion by phsicians

Target sample size

100


Research contact person

Name of lead principal investigator

1st name Makoto
Middle name
Last name Ohara

Organization

Showa University School of Medicine

Division name

Division of Diabetes and Endocrinology, Department of Internal Medicine

Zip code

142-8888

Address

1-5-8 Hatanodai, Shinagawa-ku, Tokyo

TEL

0337848129

Email

s6018@nms.ac.jp


Public contact

Name of contact person

1st name ohara
Middle name
Last name makoto

Organization

Showa University School of Medicine

Division name

Division of Diabetes and Endocrinology, Department of Internal Medicine

Zip code

142-8888

Address

1-5-8 Hatanodai, Shinagawa-ku, Tokyo

TEL

0337848129

Homepage URL


Email

s6018@nms.ac.jp


Sponsor or person

Institute

Showa University School of Medicine, Division of Diabetes and Endocrinology, Department of Internal Medicine

Institute

Department

Personal name



Funding Source

Organization

Showa University School of Medicine, Division of Diabetes and Endocrinology, Department of Internal Medicine

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Ethics comittee specializing in human subgects reserch at the Showa University

Address

1-5-8 Hatanodai, Shinagawa-ku, Tokyo

Tel

0337848129

Email

s6018@nms.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2021 Year 01 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2019 Year 09 Month 30 Day

Date of IRB

2019 Year 09 Month 30 Day

Anticipated trial start date

2019 Year 10 Month 01 Day

Last follow-up date

2021 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

nothing


Management information

Registered date

2020 Year 09 Month 17 Day

Last modified on

2022 Year 01 Month 04 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000043852


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name